United States· US:70771-1887_586136d7-1c08-4507-a8fc-946d5cbefebb
Sitagliptin and Metformin Hydrochloride
A metformin and sitagliptin product containing sitagliptin; metformin hydrochloride, registered in United States by Zydus Lifesciences Limited. The same ATC class is registered in 14 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Metformin and sitagliptin is registered in 14 of 19 countries.
Countries holding a registration under ATC A10BD07 (metformin and sitagliptin), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Metformin and sitagliptin · ATC A10BD07
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- SITAGLIPTIN; METFORMIN HYDROCHLORIDE
- Manufacturer
- Zydus Lifesciences Limited
- Country
- United States (US)
- ATC code
- A10BD07
- ATC class
- Metformin and sitagliptin
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11707711887660 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70771-1887-6)
- ndc1170771-1887-6
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for metformin and sitagliptin.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Metformin and sitagliptin · interactions on record
3 records
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under A10BD07
Metformin and sitagliptin, as other registers publish it.
- ItalyADIABINPHARMEXTRACTA S.P.A.
- ItalyADIABINPHARMEXTRACTA S.P.A.
- PolandAnsifora DuoVipharm S.A.
- CzechiaANSIFORA DUOVipharm S.A., Ożarów Mazowiecki
- CzechiaANSIFORA DUOVipharm S.A., Ożarów Mazowiecki
- CzechiaANSIFORA DUOVipharm S.A., Ożarów Mazowiecki
- CzechiaANSIFORA DUOVipharm S.A., Ożarów Mazowiecki
- CzechiaANSIFORA DUOVipharm S.A., Ożarów Mazowiecki
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b090ee24-705f-4652-98da-1efb49a66dec GET /v1/drugs/b090ee24-705f-4652-98da-1efb49a66dec?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "50; 500",
"substance": "SITAGLIPTIN; METFORMIN HYDROCHLORIDE",
"productndc": "70771-1887",
"dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1",
"application_number": "NDA216778",
"marketing_category": "NDA AUTHORIZED GENERIC"
}See everything about metformin and sitagliptin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.